Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer

University of Michigan Rogel Cancer Center

Status: Terminated

Conditions: Metastatic Breast Cancer

Treatments: Procedure: Bone marrow aspirates and biopsy

Study type: Observational

Funder types: Other

Identifiers

NCT01975597

HUM00075575 (Other Identifier)

UMCC 2013.053

Details and patient eligibility

About

This is a feasibility study to demonstrate the team's ability to collect bone marrow aspirates and biopsies for research purposes from women with metastatic breast cancer.

Enrollment: 8 patients

Sex: All

Ages: 21+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with metastatic breast cancer (any site) age 21 or older
• Patients willing and able to provide informed consent & perform study procedures
• Patients may enroll with recently (with 2 months) progressive tumor burden
• Performance status of 0,1 or 2

Exclusion criteria

• Patients unable or unwilling to provide informed consent and or perform study procedures
• Patients with active, uncontrolled coagulopathy
• Patients on treatment dose anticoagulation or an International Normalised Ratio of 2 or greater if on warfarin
• Patients who are known to be pregnant are not eligible to participate in this study during the time of the pregnancy

Trial design

8 participants in 1 patient group

Bone marrow aspirates and biopsy

Treatment:

Procedure: Bone marrow aspirates and biopsy